Evonik Evonik

X

Find Sabizabulin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

VERU-111
Also known as: Veru-111, 1332881-26-1, 37l1jx37j5, (2-(1h-indol-3-yl)-1h-imidazol-4-yl)(3,4,5-trimethoxyphenyl)methanone, [2-(1h-indol-3-yl)-1h-imidazol-5-yl]-(3,4,5-trimethoxyphenyl)methanone, [2-(1h-indol-3-yl)-1h-imidazol-5-yl](3,4,5-trimethoxyphenyl)methanone
Molecular Formula
C21H19N3O4
Molecular Weight
377.4  g/mol
InChI Key
WQGVHOVEXMOLOK-UHFFFAOYSA-N
FDA UNII
37L1JX37J5

Sabizabulin is an orally bioavailable, small molecule tubulin inhibitor, with potential antineoplastic, antiviral and anti-inflammatory activities. Upon oral administration, sabizabulin binds to the colchicine-binding site of alpha- and beta-tubulin subunits of microtubules and crosslinks the microtubules, thereby inhibiting microtubule polymerization in tumor blood vessel endothelial cells and tumor cells. This blocks the formation of the mitotic spindle and leads to cell cycle arrest at the G2/M phase. As a result, this agent disrupts the tumor vasculature, tumor blood flow, deprives tumor cells of nutrients, and induces apoptosis. In addition, as microtubules plays an important role in intracellular transport, the inhibition of its polymerization may disrupt the transport of the androgen receptor (AR) into the cell nucleus, as well as virus trafficking around the cell. This may decrease viral replication and assembly. Inhibition of tubulin polymerization may also inhibit the release of pro-inflammatory cytokines and disrupt inflammatory cell activities. Sabizabulin is not a substrate of P-glycoprotein (Pgp), an efflux pump that when overexpressed, may confer resistance to taxane agents.
1 2D Structure

VERU-111

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[2-(1H-indol-3-yl)-1H-imidazol-5-yl]-(3,4,5-trimethoxyphenyl)methanone
2.1.2 InChI
InChI=1S/C21H19N3O4/c1-26-17-8-12(9-18(27-2)20(17)28-3)19(25)16-11-23-21(24-16)14-10-22-15-7-5-4-6-13(14)15/h4-11,22H,1-3H3,(H,23,24)
2.1.3 InChI Key
WQGVHOVEXMOLOK-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC1=CC(=CC(=C1OC)OC)C(=O)C2=CN=C(N2)C3=CNC4=CC=CC=C43
2.2 Other Identifiers
2.2.1 UNII
37L1JX37J5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (2-(1h-indol-3-yl)-1h-imidazol-5-yl)-(3,4,5-trimethoxyphenyl)methanone

2. Methanone, (2-(1h-indol-3-yl)-1h-imidazol-5-yl)(3,4,5-trimethoxyphenyl)-

3. Veru-111

2.3.2 Depositor-Supplied Synonyms

1. Veru-111

2. 1332881-26-1

3. 37l1jx37j5

4. (2-(1h-indol-3-yl)-1h-imidazol-4-yl)(3,4,5-trimethoxyphenyl)methanone

5. [2-(1h-indol-3-yl)-1h-imidazol-5-yl]-(3,4,5-trimethoxyphenyl)methanone

6. [2-(1h-indol-3-yl)-1h-imidazol-5-yl](3,4,5-trimethoxyphenyl)methanone

7. Methanone, (2-(1h-indol-3-yl)-1h-imidazol-5-yl)(3,4,5-trimethoxyphenyl)-

8. (2-(1h-indol-3-yl)-1h-imidazol-5-yl)(3,4,5-trimethoxyphenyl)methanone

9. Sabizabulin [inn]

10. Sabizabulin [who-dd]

11. Veru111

12. Schembl724794

13. Unii-37l1jx37j5

14. Chembl2163631

15. Schembl20850747

16. Gtpl11422

17. Abi-231

18. Hy-120599

19. Cs-0078414

20. S6772

21. Kum

2.4 Create Date
2011-10-11
3 Chemical and Physical Properties
Molecular Weight 377.4 g/mol
Molecular Formula C21H19N3O4
XLogP33.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count6
Exact Mass377.13755610 g/mol
Monoisotopic Mass377.13755610 g/mol
Topological Polar Surface Area89.2 Ų
Heavy Atom Count28
Formal Charge0
Complexity534
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY